Securafy Inc. introduced an end-to-end AI adoption framework addressing growing concerns around ungoverned AI use in small and mid-sized businesses. The framework is anchored by AI Under Control, a leadership guide by Rodney Hall, outlining… Read More »Securafy Sets New Standard for Responsible AI Adoption for SMB Leaders
CD Bioparticles launches specialized RNA Synthesis services for researchers to develop next-generation mRNA vaccines, gene therapies, and RNA-based therapeutics. New York, NY, United States, February 10, 2026 — CD Bioparticles, a leading manufacturer and supplier… Read More »CD Bioparticles Introduces Comprehensive RNA Synthesis Services to Accelerate LNP-mRNA Vaccine and Therapeutic Development
Even the character’s voice actor called for a redesign.
To create a safe “Kid Mode” on tablets and TVs, start by using built-in parental controls like content filtering, screen time limits, and customized profiles for different ages. Choose durable devices with protective cases to… Read More »Create a Safe “Kid Mode” on Tablets and TVs
DUBAI, UAE, Feb. 10, 2026 /PRNewswire/ — Robo.ai Inc. (NASDAQ: AIIO), a Nasdaq-listed company, today announced the execution of a definitive joint venture agreement with DaBoss.AI Inc., an embodied intelligence data technology company based… Read More »Robo.ai and DaBoss.AI Establish Joint Venture to Launch Distributed Embodied AI Data Platform
LONDON, Feb. 10, 2026 /PRNewswire/ — ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a global mobility tech provider, today announced that the aggregate US$100 million in convertible notes (the “2025 Notes”) contemplated by… Read More »ECARX Announces Completion of the Final Tranche of US$100 million Convertible Notes